vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and Sunrise New Energy Co., Ltd. (EPOW). Click either name above to swap in a different company.

Sunrise New Energy Co., Ltd. is the larger business by last-quarter revenue ($22.3M vs $16.0M, roughly 1.4× CVRx, Inc.). Sunrise New Energy Co., Ltd. runs the higher net margin — -27.1% vs -74.5%, a 47.4% gap on every dollar of revenue. On growth, CVRx, Inc. posted the faster year-over-year revenue change (4.4% vs 0.0%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Husky Energy Inc. was a Canadian petroleum company that existed from 1938 to 2021. It operated in Western and Atlantic Canada, the United States and the Asia Pacific region, with upstream and downstream business segments. In the 2020 Forbes Global 2000, Husky Energy was ranked as the 1443rd-largest public company in the world.

CVRX vs EPOW — Head-to-Head

Bigger by revenue
EPOW
EPOW
1.4× larger
EPOW
$22.3M
$16.0M
CVRX
Growing faster (revenue YoY)
CVRX
CVRX
+4.4% gap
CVRX
4.4%
0.0%
EPOW
Higher net margin
EPOW
EPOW
47.4% more per $
EPOW
-27.1%
-74.5%
CVRX

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CVRX
CVRX
EPOW
EPOW
Revenue
$16.0M
$22.3M
Net Profit
$-11.9M
$-6.0M
Gross Margin
86.3%
0.1%
Operating Margin
-69.8%
-24.3%
Net Margin
-74.5%
-27.1%
Revenue YoY
4.4%
0.0%
Net Profit YoY
-12.0%
-35.7%
EPS (diluted)
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
EPOW
EPOW
Q4 25
$16.0M
Q3 25
$14.7M
Q2 25
$13.6M
$22.3M
Q1 25
$12.3M
Q4 24
$15.3M
Q3 24
$13.4M
Q2 24
$11.8M
$22.3M
Q1 24
$10.8M
Net Profit
CVRX
CVRX
EPOW
EPOW
Q4 25
$-11.9M
Q3 25
$-12.9M
Q2 25
$-14.7M
$-6.0M
Q1 25
$-13.8M
Q4 24
$-10.7M
Q3 24
$-13.1M
Q2 24
$-14.0M
$-4.5M
Q1 24
$-22.2M
Gross Margin
CVRX
CVRX
EPOW
EPOW
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
0.1%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
0.1%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
EPOW
EPOW
Q4 25
-69.8%
Q3 25
-83.5%
Q2 25
-105.8%
-24.3%
Q1 25
-108.8%
Q4 24
-67.0%
Q3 24
-97.3%
Q2 24
-118.3%
-24.3%
Q1 24
-206.4%
Net Margin
CVRX
CVRX
EPOW
EPOW
Q4 25
-74.5%
Q3 25
-87.6%
Q2 25
-108.4%
-27.1%
Q1 25
-111.5%
Q4 24
-69.4%
Q3 24
-98.0%
Q2 24
-118.8%
-20.0%
Q1 24
-206.0%
EPS (diluted)
CVRX
CVRX
EPOW
EPOW
Q4 25
$-0.45
Q3 25
$-0.49
Q2 25
$-0.57
Q1 25
$-0.53
Q4 24
$-0.39
Q3 24
$-0.57
Q2 24
$-0.65
$-0.21
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
EPOW
EPOW
Cash + ST InvestmentsLiquidity on hand
$75.7M
$1.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$27.3M
Total Assets
$104.8M
$143.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
EPOW
EPOW
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
$1.3M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
$15.2M
Q1 24
$80.1M
Stockholders' Equity
CVRX
CVRX
EPOW
EPOW
Q4 25
$39.3M
Q3 25
$48.1M
Q2 25
$57.9M
$27.3M
Q1 25
$71.1M
Q4 24
$71.1M
Q3 24
$65.2M
Q2 24
$55.2M
$-2.8M
Q1 24
$66.3M
Total Assets
CVRX
CVRX
EPOW
EPOW
Q4 25
$104.8M
Q3 25
$111.3M
Q2 25
$119.6M
$143.0M
Q1 25
$129.6M
Q4 24
$133.4M
Q3 24
$127.7M
Q2 24
$96.0M
$141.6M
Q1 24
$106.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
EPOW
EPOW
Operating Cash FlowLast quarter
$-9.8M
$-6.9M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
EPOW
EPOW
Q4 25
$-9.8M
Q3 25
$-9.7M
Q2 25
$-7.9M
$-6.9M
Q1 25
$-12.8M
Q4 24
$-8.0M
Q3 24
$-10.4M
Q2 24
$-9.8M
$-6.9M
Q1 24
$-10.9M
Free Cash Flow
CVRX
CVRX
EPOW
EPOW
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
$-7.9M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
EPOW
EPOW
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
-35.6%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
EPOW
EPOW
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
4.4%
Q1 24
8.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

EPOW
EPOW

Segment breakdown not available.

Related Comparisons